. Alzheimer disease: Amyloid-targeting antibody performs well in phase II trial. Nat Rev Neurol. 2011 Dec;7(12):657. PubMed.

Recommends

Please login to recommend the paper.

Comments

Make a Comment

To make a comment you must login or register.

Comments on this content

No Available Comments